Scott L Purga

Pulmonary tumour thrombotic microangiopathy as a cause of new-onset pulmonary hypertension in a patient with metastatic low-grade serous ovarian cancer

N. Narula, E. Horn, M. Karas, 2015, BMJ Case Reports.

Implementation of Cholesterol-Lowering Therapy to Reduce Cardiovascular Risk in Persons Living with HIV

R. Rosenson, Joshua Schulman-Marcus, Sulagna Mookherjee, 2020, Cardiovascular Drugs and Therapy.

Contribution of the left atrial remodeling to the elevated pulmonary capillary wedge pressure in patients with WHO Group II pulmonary hypertension

E. Horn, M. Torosoff, M. Karas, 2018, Journal of Echocardiography.

Recent Insights into Pharmacologic Cardiovascular Risk Reduction in Type 2 Diabetes Mellitus

M. Farkouh, Joshua Schulman-Marcus, M. Sidhu, 2017, Cardiovascular Drugs and Therapy.